Detalhe da pesquisa
1.
TACH101, a first-in-class pan-inhibitor of KDM4 histone demethylase.
Anticancer Drugs
; 34(10): 1122-1131, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067993
2.
A phase 1 study to assess the safety, pharmacokinetics, and anti-tumor activity of the androgen receptor n-terminal domain inhibitor epi-506 in patients with metastatic castration-resistant prostate cancer.
Invest New Drugs
; 40(2): 322-329, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34843005
3.
Enzalutamide in metastatic prostate cancer before chemotherapy.
N Engl J Med
; 371(5): 424-33, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24881730
4.
Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer.
Oncologist
; 21(12): 1427-1435, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27628492
5.
Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial.
Lancet Oncol
; 16(5): 509-21, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25888263
6.
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.
Prostate
; 75(8): 836-44, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683285
7.
Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study.
Lancet Oncol
; 15(6): 592-600, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24739897
8.
Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer.
J Urol
; 181(1): 363-71, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19010497
9.
CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
J Urol
; 182(1): 324-9, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19447423
10.
Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.
J Urol
; 179(1): 346-52, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18006010
11.
Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity.
Cancer Lett
; 264(2): 274-80, 2008 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-18329789
12.
Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data.
In Vivo
; 21(2): 189-204, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17436567
13.
Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
Anticancer Res
; 26(3A): 2129-35, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16827155
14.
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 70(4): 675-683, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27006332
15.
Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
Anticancer Res
; 25(6B): 4341-7, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16309238
16.
Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma.
Anticancer Res
; 25(5): 3565-73, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16101181
17.
Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model.
Anticancer Res
; 25(2A): 725-9, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15868902
18.
Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results.
Eur Urol
; 68(5): 787-94, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25687533
19.
Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2.
Anticancer Res
; 24(5A): 2869-77, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15517890
20.
Preclinical evaluation of gemcitabine/paclitaxel-interactions in human bladder cancer lines.
Anticancer Res
; 23(6C): 4805-14, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14981929